Loading provider…
Loading provider…
Pulmonary Disease Physician in Sarasota, FL
NPI: 1114258167Primary Practice Location
Intercoastal Medical Group Inc
943 S Beneva Rd, Sarasota, FL
Primary Employer
Viemed
viemed.com
HQ Phone
Get M.D. Ryan's Phone Numberphone_androidMobile
Get M.D. Ryan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2022 - 2027
IL State Medical License
2012 - 2023
CO State Medical License
2014 - 2017

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University Of Minnesota Medical School
med.umn.edu
Medical School
Until 2009
University of Colorado
Fellowship • Pulmonary Disease and Critical Care Medicine
2013 - 2016
University of Chicago
Residency • Internal Medicine
2009 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 322 | 661 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 269 | 657 |
| 3 | 94729Measurement of lung diffusing capacity | 242 | 254 |
| 4 | 94727Test to determine lung volumes using gas dilution or washout | 240 | 251 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 232 | 232 |
Anti-interleukin therapy in asthma.
Authors: Dunn, R M, Wechsler, M E
Journal: Clin Pharmacol Ther
Publication Date: 2014-12-15
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.
Authors: Laurie Manka, Yeshai Dollin
Journal: J Allergy Clin Immunol Pract
Publication Date: 2020-10-14
Asthma in the elderly and late-onset adult asthma.
Lead Sponsor: Nitto Denko Corporation
Intervention / Treatment: DRUG: ND-L02-s0201 (High Dose), OTHER: Other: Placebo, DRUG: ND-L02-s0201 (Low Dose)